Search research articles
Contact Us
Filters
Showing results (21-30 of 45) with videos related to
Page
of 5
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 1988
Recombinant interferon alfa-2a in metastatic renal cell carcinoma: assessment of antitumor activity and anti-interferon antibody formation
R A Figlin, J B deKernion, E Mukamel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1985
Phase II study of recombinant leukocyte A interferon (IFN-rA) plus cimetidine in disseminated malignant melanoma
E T Creagan, D L Ahmann, S J Green, et al.
Cancer Treatment Reports
|
May 1, 1986
Phase II trials of recombinant leukocyte A interferon in disseminated malignant melanoma: results in 96 patients
E T Creagan, D L Ahmann, S Frytak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 1986
Phase I study of a combination of recombinant interferon-alpha and recombinant interferon-gamma in cancer patients
R Kurzrock, M G Rosenblum, J R Quesada, et al.
Cancer Treatment Reports
|
September 1, 1985
Phase II study of recombinant alpha interferon in the treatment of advanced non-small cell lung carcinoma
S M Grunberg, R A Kempf, L M Itri, et al.
American Journal of Clinical Oncology
|
February 1, 1982
Phase II trial of VP-16-213 in non-small-cell lung cancer
L M Itri, R J Gralla, R A Chapman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1986
Clinical trial of recombinant leukocyte A interferon as initial therapy for favorable histology non-Hodgkin's lymphomas and chronic lymphocytic leukemia. An Eastern Cooperative Oncology Group pilot study
M J O'Connell, J P Colgan, M M Oken, et al.
Journal of Interferon Research
|
September 1, 1989
Incidence and clinical significance of neutralizing antibodies in patients receiving recombinant interferon-alpha 2a
L M Itri, M I Sherman, A V Palleroni, et al.
Cancer
|
February 1, 1987
Incidence and clinical significance of neutralizing antibodies in patients receiving recombinant interferon alfa-2a by intramuscular injection
L M Itri, M Campion, R A Dennin, et al.
Cancer Treatment Reports
|
November 1, 1983
Phase I clinical trial of 13-cis-retinoic acid in myelodysplastic syndromes
E J Gold, R H Mertelsmann, L M Itri, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 45) with videos related to
Sort By:
Page
of 5
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 1988
Recombinant interferon alfa-2a in metastatic renal cell carcinoma: assessment of antitumor activity and anti-interferon antibody formation
R A Figlin, J B deKernion, E Mukamel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1985
Phase II study of recombinant leukocyte A interferon (IFN-rA) plus cimetidine in disseminated malignant melanoma
E T Creagan, D L Ahmann, S J Green, et al.
Cancer Treatment Reports
|
May 1, 1986
Phase II trials of recombinant leukocyte A interferon in disseminated malignant melanoma: results in 96 patients
E T Creagan, D L Ahmann, S Frytak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 1986
Phase I study of a combination of recombinant interferon-alpha and recombinant interferon-gamma in cancer patients
R Kurzrock, M G Rosenblum, J R Quesada, et al.
Cancer Treatment Reports
|
September 1, 1985
Phase II study of recombinant alpha interferon in the treatment of advanced non-small cell lung carcinoma
S M Grunberg, R A Kempf, L M Itri, et al.
American Journal of Clinical Oncology
|
February 1, 1982
Phase II trial of VP-16-213 in non-small-cell lung cancer
L M Itri, R J Gralla, R A Chapman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1986
Clinical trial of recombinant leukocyte A interferon as initial therapy for favorable histology non-Hodgkin's lymphomas and chronic lymphocytic leukemia. An Eastern Cooperative Oncology Group pilot study
M J O'Connell, J P Colgan, M M Oken, et al.
Journal of Interferon Research
|
September 1, 1989
Incidence and clinical significance of neutralizing antibodies in patients receiving recombinant interferon-alpha 2a
L M Itri, M I Sherman, A V Palleroni, et al.
Cancer
|
February 1, 1987
Incidence and clinical significance of neutralizing antibodies in patients receiving recombinant interferon alfa-2a by intramuscular injection
L M Itri, M Campion, R A Dennin, et al.
Cancer Treatment Reports
|
November 1, 1983
Phase I clinical trial of 13-cis-retinoic acid in myelodysplastic syndromes
E J Gold, R H Mertelsmann, L M Itri, et al.
Page
of 5